Skip to main content
Top
Published in: Clinical Rheumatology 11/2008

01-11-2008 | Original Article

A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia

Author: Abdurahman Saud Al Arfaj

Published in: Clinical Rheumatology | Issue 11/2008

Login to get access

Abstract

To find the incidence, characteristics, method of treatment, and outcome of synovial fluid culture-positive septic arthritis, all newly admitted cases of synovial fluid culture-positive septic arthritis to King Khalid University Hospital, Riyadh, Saudi Arabia were studied prospectively during August 2005 to July 2006 and only those with positive synovial fluid culture septic arthritis were included in the analysis. Demographic, clinical, hematological, biochemical, microbiological, radiological, and histopathological data along with the interventional and surgical procedures and the functional outcome related to the joint involved were recorded. Of the 42 patients admitted, only 12 fulfilled the study criteria of having positive synovial fluid culture. Annual incidence was estimated to be 2.13 per 100,000 inhabitants. The mean disease duration before diagnosis and treatment was 10.42 ± 2.9 days. The affected joints were six knees, three hips, two shoulders, and one with hip and knee involvement. Two patients had rheumatoid arthritis, two had osteoarthritis, and one had sickle cell disease. The most common infecting organism was Staphylococcus aureus, which caused eight of the infections (66.7%), one Salmonella, one Staphylococcus epidermidis, one Enterobacter cloacae, and one Mycobacterium tuberculosis. The septic arthritis in 4 (33.3%) cases followed previous orthopedic intervention. Blood cultures were positive in three patients, all with S. aureus. White blood cell count was elevated in 3 (25%) patients. All patients received intravenous antibiotic for the initial 2 weeks, the most commonly used antibiotic was flucloxacillin. There were no deaths due to septic arthritis. The functional outcome was excellent to good. Septic arthritis is less prevalent in our community, and the most frequent organism is Staphylococcus. However, special risk factors favor other organisms such as Salmonella and Enterobacter. Previous orthopedic intervention is an important risk factor. Mortality due to septic arthritis is lower than reported elsewhere.
Literature
1.
go back to reference Le Dantec L, Maury F, Flipo RM et al (1996) Peripheral pyogenic arthritis: a study of one hundred seventy-nine cases. Rev Rhum Engl Ed 63(2):103–110PubMed Le Dantec L, Maury F, Flipo RM et al (1996) Peripheral pyogenic arthritis: a study of one hundred seventy-nine cases. Rev Rhum Engl Ed 63(2):103–110PubMed
2.
go back to reference Ryan MJ, Kavanagh R, Wall PG et al (1997) Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 36(3):370–373PubMedCrossRef Ryan MJ, Kavanagh R, Wall PG et al (1997) Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 36(3):370–373PubMedCrossRef
3.
go back to reference Morgan DS, Fisher D, Merianos A et al (1996) An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117(3):423–428PubMed Morgan DS, Fisher D, Merianos A et al (1996) An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect 117(3):423–428PubMed
4.
go back to reference Kaandorp CJ, Dinant HJ, Van de Laar MA et al (1997) Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 56(8):470–475PubMed Kaandorp CJ, Dinant HJ, Van de Laar MA et al (1997) Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis 56(8):470–475PubMed
5.
go back to reference Kaandorp CJ, Van Schaardenburg D, Krijnen P et al (1995) Risk factors for septic arthritis in patients with joint disease: a prospective study. Arthritis Rheum 38(12):1819–1825PubMedCrossRef Kaandorp CJ, Van Schaardenburg D, Krijnen P et al (1995) Risk factors for septic arthritis in patients with joint disease: a prospective study. Arthritis Rheum 38(12):1819–1825PubMedCrossRef
6.
go back to reference Kaandorp CJ, Dinant HJ, Van Schaardenburg D et al (1994) Septic arthritis in Amsterdam: potential targets for prevention. Br J Rheumatol 34(Sup):113 Kaandorp CJ, Dinant HJ, Van Schaardenburg D et al (1994) Septic arthritis in Amsterdam: potential targets for prevention. Br J Rheumatol 34(Sup):113
7.
go back to reference Al-Ballaa SR (1995) Nongonococcal septic arthritis at a major teaching hospital in Riyadh, Saudi Arabia. Ann Saudi Med 15(2):117–119PubMed Al-Ballaa SR (1995) Nongonococcal septic arthritis at a major teaching hospital in Riyadh, Saudi Arabia. Ann Saudi Med 15(2):117–119PubMed
8.
go back to reference Newman JH (1976) Review of septic arthritis through the antibiotic era. Ann Rheum Dis 35(3):198–205PubMedCrossRef Newman JH (1976) Review of septic arthritis through the antibiotic era. Ann Rheum Dis 35(3):198–205PubMedCrossRef
9.
go back to reference Gupta MN, Sturrock RD, Field M (2001 ) A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatol (Oxf) 40(1):24–30CrossRef Gupta MN, Sturrock RD, Field M (2001 ) A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatol (Oxf) 40(1):24–30CrossRef
10.
11.
go back to reference Goldenberg DL (1989) Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 32(4):496–502PubMedCrossRef Goldenberg DL (1989) Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum 32(4):496–502PubMedCrossRef
12.
go back to reference Ilahi OA, Swarna U, Hamill RJ et al (1996) Concomitant crystal and septic arthritis. Orthopedics 19(7):613–617PubMed Ilahi OA, Swarna U, Hamill RJ et al (1996) Concomitant crystal and septic arthritis. Orthopedics 19(7):613–617PubMed
13.
go back to reference Yu KH, Luo SF, Liou LB, Wu YJ, Tsai WP, Chen JY, Ho HH (2003) Concomitant septic and gouty arthritis: an analysis of 30 cases. Rheumatol (Oxf) 42(9):1062–1066CrossRef Yu KH, Luo SF, Liou LB, Wu YJ, Tsai WP, Chen JY, Ho HH (2003) Concomitant septic and gouty arthritis: an analysis of 30 cases. Rheumatol (Oxf) 42(9):1062–1066CrossRef
14.
go back to reference Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (1999) Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 58(4):214–219PubMed Weston VC, Jones AC, Bradbury N, Fawthrop F, Doherty M (1999) Clinical features and outcome of septic arthritis in a single UK Health District 1982–1991. Ann Rheum Dis 58(4):214–219PubMed
15.
go back to reference Cooper C, Cawley MI (1986) Bacterial arthritis in an English Health District: a 10 year review. Ann Rheum Dis 45(6):458–463PubMedCrossRef Cooper C, Cawley MI (1986) Bacterial arthritis in an English Health District: a 10 year review. Ann Rheum Dis 45(6):458–463PubMedCrossRef
16.
go back to reference Manshady BM, Thompson GR, Weiss JJ (1980) Septic Arthritis in a general hospital 1966–1977. J Rheumatol 7(4):523–530PubMed Manshady BM, Thompson GR, Weiss JJ (1980) Septic Arthritis in a general hospital 1966–1977. J Rheumatol 7(4):523–530PubMed
17.
go back to reference Gupta MN, Sturrock RD, Field M (2003) Prospective comparative study of patients with culture proven and high suspicion of adult-onset septic arthritis. Ann Rheum Dis 62(4):327–331PubMedCrossRef Gupta MN, Sturrock RD, Field M (2003) Prospective comparative study of patients with culture proven and high suspicion of adult-onset septic arthritis. Ann Rheum Dis 62(4):327–331PubMedCrossRef
18.
go back to reference Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiere JL, Sauvezie B (2002) No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis 61(3):267–269PubMedCrossRef Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussiere JL, Sauvezie B (2002) No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis 61(3):267–269PubMedCrossRef
19.
go back to reference Eder L, Zisman D, Rozenbaum M, Rosner I (2005) Clinical features and aetiology of septic arthritis in northern Israel. Rheumatol (Oxf) 44(12):1559–1563CrossRef Eder L, Zisman D, Rozenbaum M, Rosner I (2005) Clinical features and aetiology of septic arthritis in northern Israel. Rheumatol (Oxf) 44(12):1559–1563CrossRef
20.
go back to reference Hook EW (1990) Septic gonococcal arthritis is much more common in the USA than in UK. Br J Rheumatol 29(4):283PubMedCrossRef Hook EW (1990) Septic gonococcal arthritis is much more common in the USA than in UK. Br J Rheumatol 29(4):283PubMedCrossRef
21.
go back to reference Gravallese EM, Weissman BN, Brodsky G et al (1995) Loosening of a revision total hip replacement in a 60-year old woman with long standing rheumatoid arthritis. Arthritis Rheum 38(9):1315–1324PubMedCrossRef Gravallese EM, Weissman BN, Brodsky G et al (1995) Loosening of a revision total hip replacement in a 60-year old woman with long standing rheumatoid arthritis. Arthritis Rheum 38(9):1315–1324PubMedCrossRef
22.
go back to reference Gillespie WJ (1997) Prevention and management of infection after total joint replacement (review). Clin Infect Dis 25(6):1310–1317PubMedCrossRef Gillespie WJ (1997) Prevention and management of infection after total joint replacement (review). Clin Infect Dis 25(6):1310–1317PubMedCrossRef
24.
go back to reference Chandrasekar PH, Narula AP (1986) Bone and joint infections in intravenous drug abusers. Rev Infect Dis 8(6):904–911PubMed Chandrasekar PH, Narula AP (1986) Bone and joint infections in intravenous drug abusers. Rev Infect Dis 8(6):904–911PubMed
25.
go back to reference Brancos MA, Gatell JM, Guanabens N et al (1997) Estudio prospective de las arthritis septicas de un hospital general. Comparacion de distintos grupos de reisgo y valoracion de una pauta terapeutica medico-quirurgica preestablecida. Med Clin 87:45–48 Brancos MA, Gatell JM, Guanabens N et al (1997) Estudio prospective de las arthritis septicas de un hospital general. Comparacion de distintos grupos de reisgo y valoracion de una pauta terapeutica medico-quirurgica preestablecida. Med Clin 87:45–48
26.
go back to reference Goldenberg DL, Reed JI (1985) Bacterial arthritis. N Engl J Med 312(12):764–771PubMed Goldenberg DL, Reed JI (1985) Bacterial arthritis. N Engl J Med 312(12):764–771PubMed
27.
go back to reference Al-Salem AH, Ahmed HA, Qaisaruddin S, Al-Jam’a A, Elbashier AM, Al-Dabbous I (1992) Osteomyelitis and septic arthritis in sickle cell disease in the eastern province of Saudi Arabia. Int Orthop 16(4):398–402PubMedCrossRef Al-Salem AH, Ahmed HA, Qaisaruddin S, Al-Jam’a A, Elbashier AM, Al-Dabbous I (1992) Osteomyelitis and septic arthritis in sickle cell disease in the eastern province of Saudi Arabia. Int Orthop 16(4):398–402PubMedCrossRef
28.
go back to reference Neonato MG, Lu CY, Guilloud-Bataille M et al (1999) Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet 7(6):679–686PubMedCrossRef Neonato MG, Lu CY, Guilloud-Bataille M et al (1999) Genetic polymorphism of the mannose-binding protein gene in children with sickle cell disease: identification of three new variant alleles and relationship to infections. Eur J Hum Genet 7(6):679–686PubMedCrossRef
29.
go back to reference Tamouza R, Neonato MG, Busson M et al (2002) Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 63(3):194–199PubMedCrossRef Tamouza R, Neonato MG, Busson M et al (2002) Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 63(3):194–199PubMedCrossRef
30.
go back to reference Sankaran-Kutty M, Sadat-Ali M, Kutty MK (1988) Septic arthritis in sickle cell disease. Int Orthop 12(3):255–257PubMedCrossRef Sankaran-Kutty M, Sadat-Ali M, Kutty MK (1988) Septic arthritis in sickle cell disease. Int Orthop 12(3):255–257PubMedCrossRef
31.
go back to reference Kaandorp CJ, Krijnen P, Moens HJ et al (1997) The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum 40(5):884–892PubMedCrossRef Kaandorp CJ, Krijnen P, Moens HJ et al (1997) The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum 40(5):884–892PubMedCrossRef
32.
go back to reference Yang S, Ramachandran P, Hardick A et al (2008) Rapid PCR-based diagnosis of septic arthritis by early gram-type classification and pathogen identification. J Clin Microbiol 46(4):1386–1390PubMedCrossRef Yang S, Ramachandran P, Hardick A et al (2008) Rapid PCR-based diagnosis of septic arthritis by early gram-type classification and pathogen identification. J Clin Microbiol 46(4):1386–1390PubMedCrossRef
Metadata
Title
A prospective study of the incidence and characteristics of septic arthritis in a teaching hospital in Riyadh, Saudi Arabia
Author
Abdurahman Saud Al Arfaj
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 11/2008
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-008-0934-9

Other articles of this Issue 11/2008

Clinical Rheumatology 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.